Advanced Biomed Inc.

Sign in to save

Sign in to set an alert

Tickers: ADVB
Headquarters: Not recorded
SEC CIK: 0001941029
Website: Not recorded

Closing prices

Too many attempts. Please wait a minute and try again.

Drugs

No drugs from this company are tracked yet.

FDA-approved applications

Too many attempts. Please wait a minute and try again.

Catalysts

No catalysts yet. Editors add each date together with its source.

Deals

No approved deals involve this company yet.

Reported fundamentals (SEC XBRL)

Too many attempts. Please wait a minute and try again.

SEC filings

SEC filings from Advanced Biomed Inc., newest first
Form	Filed	What it covers	Document
10-K	13 Oct 2026Event 30 Jun 2026	Annual report (10-K)	View Annual report (10-K) filed 13 Oct 2026 on sec.gov (opens in a new tab)Filing index for 0001213900-26-109029 (opens in a new tab)
4	20 Aug 2026Event 27 Jul 2026	Insider transaction report (Form 4)	View Insider transaction report (Form 4) filed 20 Aug 2026 on sec.gov (opens in a new tab)Filing index for 0001079973-26-001162 (opens in a new tab)
8-K	17 Jul 2026Event 14 Jul 2026	Current report (8-K) Termination of a material definitive agreement (Item 1.02) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 17 Jul 2026 on sec.gov (opens in a new tab)Filing index for 0001213900-26-079233 (opens in a new tab)
8-K	1 Jul 2026Event 30 Jun 2026	Current report (8-K) Shareholder vote results (Item 5.07)	View Current report (8-K) filed 1 Jul 2026 on sec.gov (opens in a new tab)Filing index for 0001213900-26-074306 (opens in a new tab)
8-K	30 Jun 2026	Current report (8-K) Entry into a material definitive agreement (Item 1.01) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 30 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001213900-26-073735 (opens in a new tab)
DEF 14A	4 Jun 2026Event 30 Jun 2026	Proxy statement (DEF 14A)	View Proxy statement (DEF 14A) filed 4 Jun 2026 on sec.gov (opens in a new tab)Filing index for 0001213900-26-065017 (opens in a new tab)
10-Q	15 May 2026Event 31 Mar 2026	Quarterly report (10-Q)	View Quarterly report (10-Q) filed 15 May 2026 on sec.gov (opens in a new tab)Filing index for 0001213900-26-057226 (opens in a new tab)
8-K	1 May 2026Event 28 Apr 2026	Current report (8-K) Completion of acquisition or disposition of assets (Item 2.01) Unregistered sales of equity securities (Item 3.02) Departure or appointment of directors or officers (Item 5.02) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 1 May 2026 on sec.gov (opens in a new tab)Filing index for 0001213900-26-051028 (opens in a new tab)
8-K	14 Apr 2026Event 13 Apr 2026	Current report (8-K) Entry into a material definitive agreement (Item 1.01) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 14 Apr 2026 on sec.gov (opens in a new tab)Filing index for 0001213900-26-043557 (opens in a new tab)
8-K	3 Apr 2026Event 2 Apr 2026	Current report (8-K) Entry into a material definitive agreement (Item 1.01) Financial statements and exhibits (Item 9.01)	View Current report (8-K) filed 3 Apr 2026 on sec.gov (opens in a new tab)Filing index for 0001213900-26-040030 (opens in a new tab)

Source: SEC EDGAR. Each row links to the filing on sec.gov.

Related news

No recent headlines mention this company.

Insider transactions

Last 90 days of Form 4 filings, from 3 Aug 2026 (US Eastern dates).

Buys code P: None in this period
Sells code S: None in this period
Other all other codes: None in this period

Last transaction: 27 Jul 2026

Insider filings are public records and are not a recommendation. Source: SEC EDGAR.

Sources

Editor source (opens in a new tab) Licence: editorial. Entered by an editor, not fetched automatically
SEC EDGAR submissions (opens in a new tab) Licence: public-domain. Fetched 25 Oct 2026

Nothing on this page is investment advice.